Drawing for MEDIFIT

USPTO serial 99902257

MEDIFIT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MARTIN, CHRISTIAN EDMUND
Law office
TMO LAW OFFICE 134

What this means

Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.

Status 638: Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months.

Need help with MEDIFIT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John C. McElwaine

John C. McElwaine NELSON MULLINS RILEY & SCARBOROUGH LLP301 South College StreetIP Dept. 23rd FloorCharlotte, NC 28202

Goods and services

ClassDescriptionStatusFirst use
042Software as a service (SAAS) services featuring software for for self-assessment of potential clinical trial participants by converting clinical trial inclusion and exclusion criteria into structured, plain-language questionnaires and providing informational, non-diagnostic, indicative assessments of potential medical suitability based on user-provided responses; the foregoing not for use as a medical device, nor for diagnosing, treating, or making clinical decisions, and not as a substitute for review by a clinician, investigator, trial site; Software as a service (SAAS) services featuring software for nor as a substitute for review by a clinician, investigator, trial site, or other healthcare professionalACTIVEJun 10, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 30, 2026DOCKASSIGNED TO EXAMINER—
Oct 26, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 24, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 24, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance